Journal of Bone and Mineral Research

Cover image for Vol. 29 Issue 10

Edited By: Juliet E Compston

Impact Factor: 6.589

ISI Journal Citation Reports © Ranking: 2013: 12/123 (Endocrinology & Metabolism)

Online ISSN: 1523-4681

Access Chinese Articles now online


Volume 3, Issue 2


骨与骨骼肌:休戚相关
Bone and Skeletal Muscle: Neighbors With Close Ties

双膦酸盐与转子下骨折、股骨干骨折以及非典型性股骨骨折的发 生风险:系统综述以及荟萃分析
Bisphosphonates and Risk of Subtrochanteric, Femoral Shaft, and Atypical Femur Fracture: A Systematic Review and Meta-Analysis

经皮椎体成形术后椎体骨折发生的危险因素
Risk Factors for the Development of Vertebral Fractures After Percutaneous
Vertebroplasty

骨骼和骨骼肌交互作用论坛:ASBMR 研讨会进程总结
Forum on Bone and Skeletal Muscle Interactions: Summary of the Proceedings of an ASBMR Workshop

C-反应蛋白、骨强度与9 年骨折风险:来自全国妇女健康研究 (SWAN) 的结果
C-Reactive Protein, Bone Strength, and Nine-Year Fracture Risk: Data From theStudy of Women’s Health Across the Nation (SWAN)

妇女骨质疏松性骨折的风险评估工具:复杂还是简单?系统性评价
Risk Assessment Tools to Identify Women With Increased Risk of Osteoporotic
Fracture: Complexity or Simplicity? A Systematic Review

骨髓脂肪成分—绝经女性脆性骨折的一种新影像生物标记物
Bone Marrow Fat Composition as a Novel Imaging Biomarker in Postmenopausal
Women With Prevalent Fragility Fractures

慢性肾衰患者皮质骨骨量的快速丢失
Rapid Cortical Bone Loss in Patients With Chronic Kidney Disease

多点定量式超声预测骨质疏松骨折,5 年以上的随访:加拿大多 中心骨质疏松症研究
Multisite Quantitative Ultrasound for the Prediction of Fractures Over 5 Years of
Follow-up: The Canadian Multicentre Osteoporosis Study

Volume 3, Issue 1

骨质疏松症的目标导向治疗
Goal-Directed Treatment of Osteoporosis

骨质疏松症的目标导向治疗(述评)
Goal-Directed Therapy in Osteoporosis

PTH 1-34、PTH 1-84和唑来膦酸对绝经后骨质疏松妇女骨微结构和预计骨强度的不同作用:一项应用HR-pQCT的18个月的开放标签观察性研究
Differing Effects of PTH 1–34, PTH 1–84, and Zoledronic Acid on Bone Microarchitecture and Estimated Strength in Postmenopausal Women With Osteoporosis: An 18-Month Open-Labeled Observational Study Using HR-pQCT

降钙素:生理作用还是幻想作用?
Calcitonin: Physiology or Fantasy?

观察性研究—仅告诉我们想听到什么还是告诉我们需要去关注哪里?

Observational Studies—Just Telling Us What We Want To Hear or Telling Us Where We Need to Look?

抗骨质疏松治疗对糖代谢的影响:来自FIT、HORIZON-PFT, FREEDOM试验的研究结果
Effects of Antiresorptive Therapies on Glucose Metabolism: Results From the FIT, HORIZON-PFT, and FREEDOM Trials

椎体成形术和保守疗法治疗伴有疼痛的骨质疏松性椎体骨折的荟萃分析
Meta-Analysis of Vertebral Augmentation Compared With Conservative Treatment for Osteoporotic Spinal Fractures

RBMS3与ZNF516基因-基因相互作用影响骨密度

Gene-Gene Interaction Between RBMS3 and ZNF516 Influences Bone Mineral Density

美国老年人血清25羟维生素D水平与重要部位骨质疏松性骨折风险
Serum 25-Hydroxyvitamin D and Risk of Major Osteoporotic Fractures in Older U.S. Adults

绝经前和绝经后华裔美国女性与白人女性在骨微结构和机械能力上的差异
Premenopausal and Postmenopausal Differences in Bone Microstructure and Mechanical Competence in Chinese-American and White Women

阿仑膦酸钠或雷洛昔芬治疗的绝经后骨质疏松妇女联用或换用特立帕肽对髋关节和脊柱强度的影响
Hip and Spine Strength Effects of Adding Versus Switching to Teriparatide in Postmenopausal Women With Osteoporosis Treated With Prior Alendronate or Raloxifene

Volume 2, Issue 2

地诺单抗减少绝经后妇女骨质疏松性骨折风险,特别是经FRAX 评估具有中度到高骨折风险的患者
Denosumab Reduces the Risk of Osteoporotic Fractures in Postmenopausal Women, Particularly in Those With Moderate to High Fracture Risk as Assessed With FRAX

肿瘤源性骨软化症:一个在中国重要的成人起病的低磷性骨软化 症病因(39 例病例报告及文献综述)
Tumor-Induced Osteomalacia: An Important Cause of Adult-Onset Hypophosphatemic Osteomalacia in China: Report of 39 Cases and Review of the Literature

间断甲状旁腺素治疗可以激活静止的衬里层细胞为活跃的成骨 细胞
Intermittent Parathyroid Hormone Administration Converts Quiescent Lining Cells to Active Osteoblasts


胸椎后凸及矢状面曲线对椎体压力负荷的影响
The Effect of Thoracic Kyphosis and Sagittal Plane Alignment on Vertebral Compressive Loading

2 型糖尿病和骨
Type 2 Diabetes and Bone


关于成人骨肉瘤与特立帕肽的美国上市后监测研究:研究设计与 首个7 年的研究发现
The US Postmarketing Surveillance Study of Adult Osteosarcoma and Teriparatide: Study Design and Findings From the First 7 Years

非典型非创伤性股骨干骨折的发病率
Incidence of Atypical Nontraumatic Diaphyseal Fractures of the Femur


地诺单抗治疗骨纤维异常增殖症
Denosumab Treatment for Fibrous Dysplasia


甲状旁腺激素 1-34 替代治疗在甲状旁腺减低症相关骨病中的应用
Daily Parathyroid Hormone 1-34 Replacement Therapy for Hypoparathyroidism Induces Marked Changes in Bone Turnover and Structure


区分不同骨折部位的风险预测:来源于全球女性骨质疏松纵向研 究(GLOW) 的证据
Differing Risk Profiles for Individual Fracture Sites: Evidence From the Global Longitudinal Study of Osteoporosis in Women (GLOW)


椎体脆性和结构冗余

Vertebral Fragility and Structural Redundancy


低剂量补钙对围绝经期和绝经后期亚洲女性骨量丢失的作用: 一项随机对照研究
Effect of Low-Dose Calcium Supplements on Bone Loss in Perimenopausal and Postmenopausal Asian Women: A Randomized Controlled Trial

高血浆硬化蛋白水平预测绝经后妇女骨质疏松骨折的发生率:一项卓越中心骨质疏松研究
High Serum Sclerostin Predicts the Occurrence of Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study

blank

Volume 2, Issue 1

中国北京地区人群髋部骨折发生率迅速升高
Rapidly Increasing Rates of Hip Fracture in Beijing, China

老年妇女身高变矮:独立于脊柱骨折以外的髋部骨折和死亡的 风险
Height Loss in Older Women: Risk of Hip Fracture and Mortality Independent of Vertebral Fractures

口服25(OH)D3 与维生素D3 对血清25(OH)D 水平、下肢功能、血压、天然免疫标志物的不同影响
Oral Supplementation With 25(OH)D3 Versus Vitamin D3: Effects on 25(OH)D Levels, Lower Extremity Function, Blood Pressure, and Markers of Innate Immunity

钙敏感受体阻滞剂Ronacaleret 增加绝经后妇女的松质骨密度,但不增加皮质骨密度
Ronacaleret, a Calcium-Sensing Receptor Antagonist, Increases Trabecular but Not Cortical Bone in Postmenopausal Women

甲状旁腺激素通过改善I 型胶原分布而改善绝经后骨质疏松妇女 的皮质骨微结构
Parathyroid Hormone Treatment Improves the Cortical Bone Microstructure by Improving the Distribution of Type I Collagen in Postmenopausal Women With Osteoporosis

需要更多的骨密度检查,而不是更少
More Bone Density Testing Is Needed, Not Less

对老年女性进行骨密度筛查:初始检测和检测间隔
BMD Screening in Older Women: Initial Measurement and Testing Interval

骨的辐射暴露:老看法,新见解
The Irradiation of Bone: Old Idea, New Insight

分类错误不能解释补钙增加心血管疾病风险
Misclassification Does Not Explain Increased Cardiovascular Risks of Calcium Supplements

对“错误分类不能解释补充钙剂会增加心血管风险”的回应
Response to ‘‘Misclassification Does Not Explain Increased Cardiovascular Risks of Calcium Supplements’’

月经初潮前骨量较高的优秀体操运动员在退役多年后其骨量仍能
Higher Premenarcheal Bone Mass in Elite Gymnasts Is Maintained Into Young Adulthood After Long-Term Retirement From Sport: A 14-Year Follow-up

维持至青年成人水平—14 年的随访研究
Simulated Increases in Body Fat and Errors in Bone Mineral Density Measurements by DXA and QCT

FRAX 评估糖尿病患者骨折风险的研究
FRAX Underestimates Fracture Risk in Patients With Diabetes

二膦酸盐相关的非典型骨折1 例:用DXA 回顾分析其渐进性 变化
Evolution of Bisphosphonate-Related Atypical Fracture Retrospectively Observed With DXA Scanning

QCT 测量胸腰椎体强度:Framingham 临床研究
QCT Measures of Bone Strength at the Thoracic and Lumbar Spine: The Framingham Study

使用阿仑膦酸钠的患者中食管癌和胃癌的发病率和病死率
Esophageal and Gastric Cancer Incidence and Mortality in Alendronate Users

预测对抗骨吸收药物治疗反应不当的危险因素
Risk Factors for Prediction of Inadequate Response to Antiresorptives

整合的骨质疏松相关表型与全基因组的关联:有多效基因作用的 证据吗?
Genome-wide Association of an Integrated Osteoporosis-Related Phenotype: Is There Evidence for Pleiotropic Genes?

肠道菌群调节小鼠骨量
The Gut Microbiota Regulates Bone Mass in Mice

blank

Volume 1, Issue 2

X- 连锁低磷血症的临床指南
A Clinician’s Guide to X-Linked Hypophosphatemia

球囊扩张椎体后凸成形术治疗急性椎体压缩性骨折:两年随机 分组研究
Balloon Kyphoplasty for the Treatment of Acute Vertebral Compression Fractures: 2-Year Results From a Randomized Trial

世界卫生组织的绝对骨折风险模型:在非骨质疏松老年女性中, 临床危险因素是否能提高骨折预测
WHO Absolute Fracture Risk Models (FRAX): Do Clinical Risk Factors Improve Fracture Prediction in Older Women Without Osteoporosis?

糖皮质激素诱导骨质疏松的预防和治疗其不确定性
Uncertainties in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

骨小梁评分法可独立于骨密度预测骨质疏松性骨折:Manitoba 研究
Bone Microarchitecture Assessed by TBS Predicts Osteoporotic Fractures Independent of Bone Density: The Manitoba Study

在国际队列研究中利用不含BMD 的危险因素公式预测骨折发生
Predicting Fractures in an International Cohort Using Risk Factor Algorithms Without BMD

应用μCT 和间盘造影研究高腰椎骨密度与椎间盘退变的相关性
Is Greater Lumbar Vertebral BMD Associated With More Disk Degeneration? A Study Using μCT and Discography

6.5 年数据显示:单纯静脉注射唑来膦酸可以持续缓解Paget 骨病
A Single Infusion of Zoledronic Acid Produces Sustained Remissions in Paget Disease: Data to 6.5 Years

使用尿戊苷糖分析有助于提高使用骨折风险评估工具对绝经后妇 女骨折的风险评估
Urinary Pentosidine Improves Risk Classification Using Fracture Risk Assessment Tools for Postmenopausal Women

Cyr61下调减少骨肉瘤细胞浸润、迁移和转移
CYR61 Downregulation Reduces Osteosarcoma Cell Invasion, Migration, and Metastasis

髋部强度有限元分析的评估结果与女性和男性髋部骨折的关系
Association of Hip Strength Estimates by Finite-Element Analysis With Fractures in Women and Men

blank

Volume 1, Issue 1

老年女性补充钙剂与发生动脉粥样硬化性心血管疾病风险的关系:一项长达5 年的随机对照临床试验且试验后随访4.5 年的结果
Calcium supplementation and the risks of atherosclerotic vascular disease in older women: Results of a 5-year RCT and a 4.5-year follow-up

雷洛昔芬与阿仑膦酸钠联合治疗对椎体骨生物力学特性的影响
Effects of the Combination Treatment of Raloxifene and Alendronate on the Biomechanical Properties of Vertebral Bone

骨折的遗传特征及个体化预后
Genetic profiling and individualized prognosis of fracture

自发性疼痛性椎骨骨折患者的异常骨重建
Abnormal bone remodeling in patients with spontaneous painful vertebral fracture

牛奶摄入量与男女髋部骨折风险:前瞻性队列研究的荟萃分析
Milk intake and risk of hip fracture in men and women: A meta-analysis of prospective cohort studies

骨质流失是骨沉积的逆转?源于女儿– 母亲– 外祖母三代人组的横断面研究
Is bone loss the reversal of bone accrual? evidence from a cross-sectional study in daughter-mother-grandmother trios 18F– PET

显示特立帕肽在局部成骨中的显著作用
Differential effects of teriparatide on regional bone formation using 18F-fluoride positron emission tomography

成骨细胞:调控葡萄糖稳态的胰岛素靶细胞
The osteoblast: An insulin target cell controlling glucose homeostasis

模拟轻微骨折后人类腰椎力学表现的决定因素
Determinants of the mechanical behavior of human lumbar vertebrae after simulated mild fracture

欧洲人髋部骨折的前瞻性研究(EFFECT) :应用定量CT 鉴别活体内的髋部骨折
In vivo discrimination of hip fracture with quantitative computed tomography: Results from the prospective European Femur Fracture Study (EFFECT)

阻断体内成骨细胞受体– 活化Gi 信号导致特定部位皮质骨和松质骨的骨形成增加
Blockade of receptor-activated Gi signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation

甲状旁腺激素对骨髓造血干细胞的分布和破骨细胞生成潜能的调节
Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow

血清成纤维细胞生长因子-23(FGF-23) 与老年男性骨折风险的关系
Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men

美国老年人中粗隆下脆性骨折发病率趋势与双膦酸盐应用,1996-2007
Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007

SEARCH

SEARCH BY CITATION